Brief: Lidds: Positive Effects Of NanoZolid Formulation With STING

Lidds AB

15/03/2018 07:34

March 15 (Reuters) - LIDDS AB  LIDDS.ST :
    * REG-LIDDS: NANOZOLID® WITH CUTTING EDGE STING AGONIST
BECOMES A
KEY PROJECT FOR LIDDS IN IMMUNO-ONCOLOGY FIELD
    * INJECTIONS OF A NANOZOLID FORMULATED STING AGONIST PROVEN
TO
ACHIEVE SIGNIFICANT EFFECTS ON TUMOR GROWTH REDUCTION​

Source text for Eikon:  ID:nGNEbsPsCq 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))